Archer Materials Ltd's (ASX:AXE) (OTCMKTS:ARRXF) (FRA:38A) CEO Dr Mohammad Choucair speaks to Proactive's Andrew Scott after announcing they've progressed its graphene-based lab-on-a-chip device technology development with improved biochip nanofabrication capabilities. The company has successfully demonstrated that it can fabricate nanosize biosensor components of 100-150 nanometre features on silicon wafers.
Archer Materials successfully fabricates nanosize biosensor components for its biochip
